U.S. Markets close in 6 hrs 20 mins

DexCom, Inc. (DXCM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
71.220.00 (0.00%)
As of 9:40AM EDT. Market open.
People also watch
PODDNUVAABMDELGXEW
  • S
    SMD
    SMD
    Apple will release it's all in one self contained watches soon. I will cause a surge in Dexcom sales due to the perfect compatibility with the Dexcom BG sensors.
  • A
    Anna
    Anna
    Overall I think we will see upside for DXCM in the short-term. Perhaps a pullback next day or so could occur I suppose but are yall also seeing a further leg higher? check out awe-some*sto-ck*s, its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
  • T
    Tpljmpr5
    Tpljmpr5
    Has Abbot's Libre received approval yet? Wonder how much DXCM will fall when it does? Any guesses??
  • D
    Dani
    Dani
    Where's that idiot Tpljmpr5? The guy who has NEVER been right about this stock.
  • S
    SMD
    SMD
    Great tme to Buy right before earning reports. Dex will beat estimatesdue toan early start on medicare coverage & shipments.
  • T
    Tpljmpr5
    Tpljmpr5
    More laughs from DXCM management: The CEO claims to not have even seen the results of a key trial BUT he knows that they are very confident and its great technology!!!

    "Got it. And then on G6, can you comment at all on the results of the pivotal trial? Were performance results in line with the preclinical data you've previously presented?

    Kevin R. Sayer, DexCom, Inc. - CEO, President and Director

    To the credit of my team, they've not shown me the results of the pivotal study. So I can't comment. And we wouldn't anyway. We'll submit it and it'll be published later. But we're very confident in that system. It's great sensor technology with a very strong algorithm."
  • T
    Tpljmpr5
    Tpljmpr5
    "And it's our job, quite frankly, to get to the cost of the devices down to whereby we can make money there, and we will".

    This sums up everything about this company. They are a mature company in an ever increasingly competitive market with much more elegant solutions on the horizon. Yet even though they were the pioneer in this space and have had it to themselves for well over a decade they STILL cant make money. A company is worth its future free cash flows. Period. Will there be any? Most companies that have a monopoly position like DXCM has enjoyed for years figure out a way to make $$. What does that tell you about this company. If any of you bothered to listen to the call or read the transcript you would also learn that they had to raise more DEBT in the form of a convertible. They cancelled the G5 to focus on G6 (probably cause of lack of funds). They are getting paid ZERO on Medicare and even when this changes the economics are NOT good and adversely affect gross margins. I could go on and on but the rose colored glasses contingent on this board doesn't care. I wish this stock was up 20% today so I could load up again. Sales from pump patients poor, guidance for Q3 weak even though Q3'16 was super soft so guidance should have been strong....and on and on......
  • T
    Tpljmpr5
    Tpljmpr5
    @Dani: I am touched that I am the first person you think of when you wake up. Does that happen every day?? You're sweet.
  • M
    Montique
    Montique
    Dexcom Receiver & Pipeline

    The company was showing off its new touchscreen receiver, expected to launch in the August-September timeframe.

    Also on Friday just before ADA news hit that FDA approved the G5 Mobile app for Android, which had many enthused.

    In a meeting with Dexcom execs, we learned that this leading CGM company has gone from 400 employees 6 years ago to over 2,000 employees currently. Their Gen 6 sensor trials are underway, and the specifics of this system are exciting:

    it will use new sensor membranes and a new algorithm for improved performanceit will block acetaminophen, so patients can finally take Tylenol without messing up their readings (!)it will include a new transmitter and smaller, easier inserter deviceit's designed for 10-day wear, with very little calibration required: only 2 within the first 12 hours, and then one per day from then onthe new sensor will be 30-40% smallerthey hope to file with FDA by Q3 of this year, and launch in 2018

    Regarding future technology, they are of course working with Animas, Tandem and OmniPod on closed-loop system configurations. CEO Kevin Sayer tells us their first product co-developed with Google will be aimed at doctors treating patients with type 2 diabetes. A tiny new sensor code-named Fusion will be "smaller than Abbott Libre, at worst 20% the size of that," Sayer says. Wow! 

    If you're wondering what's going on with Medicare coverage of Dexcom CGM, here's the rub: CMS has mandated that Dexcom ship out to Medicare patients "everything they would need" to use the product. Since calibrations with a fingerstick meter are required, that means Dexcom has to find a traditional meter company to partner with to actually ship meters and test strips in the package with their CGM. Kinda crazy, and definitely creating delays for the company and its customers!

    Last not least, an announcement of Dexcom-Apple Watch integration was made at the recent Apple developers conference -- meaning the CGM data will be beamed directly to your watch. Once this launches, patients can not only ditch the traditional receiver, but could even leave their phones at home and just monitor BGs on their wrist. Cool.

     
  • T
    Tpljmpr5
    Tpljmpr5
    Ouch! This baby is really breaking down. Below $70......soon below $60??? How soon before its back in the $30's? Anyone care to guess.
  • F
    Furry
    Furry
    Dexcom is about ready to start shipping Medicare orders.
    As well, they have already submitted the G6 (next generation CGM) for approval.
    Dexcom is also waiting on a pending FDA approval for integration with Tandem.

    You would likely be better off at the Horse Track then betting against Dexcom.
  • T
    The T Man
    The T Man
    How is this company in business? My son recently got a new Animas pump and we have been working for months to get him the Dexcom G4 system which is integrated into his pump. Everything seems good but then Dexcom refers us to Liberty Medical to do the processing, well weeks go by and they don't seem to be doing anything. Now we find out that Dexcom referred us to Edgepark Medical for supplies and we have to start over, apparently Edgepark bought the diabetes part of Liberty Medical abruptly and nothing transferred over. Do some research online and these supplier companies have terrible reputations. This is all because we have too much insurance, Dexcom deals with our primary insurance but not our secondary insurance so they have to find a supplier that deals with both which neither Liberty Medical or Edgepark does. Our primary insurance has a 20% copay which the secondary insurance covers so we'd pay nothing.

    I'm not sure I understand why you would put a customer off months from getting set up with your product which will generate years of revenue over about $200? My guess is after all is said and done with Dexcom will net less paying a middleman company than if they just billed the primary insurance and waived our copay.

    Checked in with Medtronic and they are willing to set us up with their new pump if we trade in the current pump for $749 and work with us on the CGM and initial supplies to get us using their product. When I called and talked to the Dexcom representative to see if Dexcom would do anything like that she told me she understood if I wanted to switch to Medtronic and to let her know if I still wanted to work on getting Dexcom?

    Not sure how a company can operate basically encouraging potential customers to go to your competitor?
  • S
    SMD
    SMD
    Already going back up
  • T
    Tpljmpr5
    Tpljmpr5
    According to Yahoo Finance Forward P/E on DXCM is 6853X EPS. Yes....not a typo. And you though AMZN was expensive??? At least P/E is not negative like PODD. But it will be..........
  • S
    SMD
    SMD
    Dex will beat earnings this quarter. As expected.
  • T
    Tpljmpr5
    Tpljmpr5
    Total technical breakdown on nearly every metric. Looks bad. No earnings support. Look out below.
  • T
    Tpljmpr5
    Tpljmpr5
    So fun when this goes down.... $$$$$ :) :) :)
  • M
    Michael
    Michael
    The breakout has begun (2 weeks ago)....
  • M
    Miles
    Miles
    PKVITALITY WON TECHNOLOGY AWARD 2017 CES SHOW GLUCOSE WATCH
  • M
    Michael
    Michael
    Moved through the 50DMA like a BULL!